These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36966161)

  • 1. A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination.
    Abu Hamdh B; Nazzal Z
    Sci Rep; 2023 Mar; 13(1):4896. PubMed ID: 36966161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability.
    Fernández-de-Las-Peñas C; Palacios-Ceña D; Gómez-Mayordomo V; Palacios-Ceña M; Rodríguez-Jiménez J; de-la-Llave-Rincón AI; Velasco-Arribas M; Fuensalida-Novo S; Ambite-Quesada S; Guijarro C; Cuadrado ML; Florencio LL; Arias-Navalón JA; Ortega-Santiago R; Elvira-Martínez CM; Molina-Trigueros LJ; Torres-Macho J; Sebastián-Viana T; Canto-Diez MG; Cigarán-Méndez M; Hernández-Barrera V; Arendt-Nielsen L
    Respiration; 2022; 101(2):132-141. PubMed ID: 34569550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post COVID-19 sequelae: A prospective observational study from Northern India.
    Naik S; Haldar SN; Soneja M; Mundadan NG; Garg P; Mittal A; Desai D; Trilangi PK; Chakraborty S; Begam NN; Bhattacharya B; Maher G; Mahishi N; Rajanna C; Kumar SS; Arunan B; Kirtana J; Gupta A; Patidar D; Kodan P; Sethi P; Ray A; Jorwal P; Kumar A; Nischal N; Sinha S; Biswas A; Wig N
    Drug Discov Ther; 2021 Nov; 15(5):254-260. PubMed ID: 34719599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.
    Arjun MC; Singh AK; Pal D; Das K; G A; Venkateshan M; Mishra B; Patro BK; Mohapatra PR; Subba SH
    PLoS One; 2022; 17(12):e0278825. PubMed ID: 36538532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study.
    Wong MC; Huang J; Wong YY; Wong GL; Yip TC; Chan RN; Chau SW; Ng SC; Wing YK; Chan FK
    JMIR Public Health Surveill; 2023 Mar; 9():e42315. PubMed ID: 36645453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
    PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.
    Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA
    JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis.
    Gao P; Liu J; Liu M
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    Tenforde MW; Self WH; Adams K; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Olson SM; Kobayashi M; Verani JR; Patel MM;
    JAMA; 2021 Nov; 326(20):2043-2054. PubMed ID: 34734975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring inequalities in COVID-19 vaccination uptake and intent: results from the Canadian Community Health Survey 2021.
    Guay M; Maquiling A; Chen R; Lavergne V; Baysac DJ; Racine A; Dubé E; MacDonald SE; Gilbert NL
    BMC Public Health; 2022 Sep; 22(1):1708. PubMed ID: 36076208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.
    Funk AL; Kuppermann N; Florin TA; Tancredi DJ; Xie J; Kim K; Finkelstein Y; Neuman MI; Salvadori MI; Yock-Corrales A; Breslin KA; Ambroggio L; Chaudhari PP; Bergmann KR; Gardiner MA; Nebhrajani JR; Campos C; Ahmad FA; Sartori LF; Navanandan N; Kannikeswaran N; Caperell K; Morris CR; Mintegi S; Gangoiti I; Sabhaney VJ; Plint AC; Klassen TP; Avva UR; Shah NP; Dixon AC; Lunoe MM; Becker SM; Rogers AJ; Pavlicich V; Dalziel SR; Payne DC; Malley R; Borland ML; Morrison AK; Bhatt M; Rino PB; Beneyto Ferre I; Eckerle M; Kam AJ; Chong SL; Palumbo L; Kwok MY; Cherry JC; Poonai N; Waseem M; Simon NJ; Freedman SB;
    JAMA Netw Open; 2022 Jul; 5(7):e2223253. PubMed ID: 35867061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study.
    Menges D; Ballouz T; Anagnostopoulos A; Aschmann HE; Domenghino A; Fehr JS; Puhan MA
    PLoS One; 2021; 16(7):e0254523. PubMed ID: 34252157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of long-COVID among older adults: a cross-sectional study.
    Daitch V; Yelin D; Awwad M; Guaraldi G; Milić J; Mussini C; Falcone M; Tiseo G; Carrozzi L; Pistelli F; Nehme M; Guessous I; Kaiser L; Vetter P; Bordas-Martínez J; Durà-Miralles X; Peleato-Catalan D; Gudiol C; Shapira-Lichter I; Abecasis D; Leibovici L; Yahav D; Margalit I;
    Int J Infect Dis; 2022 Dec; 125():287-293. PubMed ID: 36191820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.